Stocks to Watch: GitLab, Joann, Travere Therapeutics

0 4

By Ben Glickman


GitLab on Monday raised its full-year guidance for adjusted earnings and revenue after third-quarter results topped analysts’ expectations. The company now expects an adjusted profit of 12 cents to 13 cents a share, compared with prior guidance of an adjusted loss of 5 cents to 8 cents a share. The stock rises 16%, to $61.65, in after-hours trading.

Joann logged a wider loss in the three months ended Oct. 28, as the fabric and sewing-products retailer’s sales sank over 4%. The company’s adjusted loss of 21 cents a share was in line with expectations. Shares fall 6.7%, to 83 cents, after-hours.

Travere Therapeutics will slash its workforce by about 20% and will dedicate resources to two ongoing programs, a treatment for a Berger’s disease and classical HCU. The company said Monday that the move would extend its cash runway into 2028. Shares rise 7.3%, to $6.75, in after-hours trading.


Write to Ben Glickman at [email protected]


Read the full article here

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy